(34) Problems with FDA's Regulation of the Antiarrhythmic Drugs Tambocor and Enkaid
: Hearings Before the Human Resources Intergovernmental Relations, Subcomm.
- Bristol Laboratories has announced that its antiarrhythmic medication, Enkaid
, will be withdrawn from the market, effective in December.
Product information, Enkaid
. Evanston, III, Bristol Laboratories, 1989
Study patients taking encainide (marketed as Enkaid
by Bristol Laboratories in Evansville, Ind.) and flecainide (marketed as Tambocor by 3M Riker in St.
Tambocor, Mexitil, Cardarone, Enkaid
, Decabid Anticonvulsants - Dilantin, phenobarbital, Tegretol, Depakene/